Aptamer Group PLC (APTA) - Total Assets
Based on the latest financial reports, Aptamer Group PLC (APTA) holds total assets worth GBX2.83 Million GBX (≈ $344.82 USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of Aptamer Group PLC for net asset value and shareholders' equity analysis.
Aptamer Group PLC - Total Assets Trend (2019–2025)
This chart illustrates how Aptamer Group PLC's total assets have evolved over time, based on quarterly financial data.
Aptamer Group PLC - Asset Composition Analysis
Current Asset Composition (June 2025)
Aptamer Group PLC's total assets of GBX2.83 Million consist of 64.3% current assets and 35.7% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 37.4% |
| Accounts Receivable | GBX532.00K | 18.8% |
| Inventory | GBX80.00K | 2.8% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX225.00K | 7.9% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2019–2025)
This chart illustrates how Aptamer Group PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Aptamer Group PLC market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aptamer Group PLC's current assets represent 64.3% of total assets in 2025, a decrease from 88.4% in 2019.
- Cash Position: Cash and equivalents constituted 37.4% of total assets in 2025, down from 52.1% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 1.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 18.8% of total assets.
Aptamer Group PLC Competitors by Total Assets
Key competitors of Aptamer Group PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fortress Biotech Inc
NASDAQ:FBIO
|
USA | $185.55 Million |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $261.73 Million |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
USA | $1.08 Billion |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
BrightGene Bio Medical Technology C
SHG:688166
|
China | CN¥5.38 Billion |
|
BioArctic AB (publ)
ST:BIOA-B
|
Sweden | Skr2.60 Billion |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Aptamer Group PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.55 | 1.27 | 2.58 |
| Quick Ratio | 1.48 | 1.17 | 2.45 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX647.00K | GBX340.00K | GBX755.23K |
Aptamer Group PLC - Advanced Valuation Insights
This section examines the relationship between Aptamer Group PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 17.56 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | 2.3% |
| Total Assets | GBX2.83 Million |
| Market Capitalization | $205.09K USD |
Valuation Analysis
Below Book Valuation: The market values Aptamer Group PLC's assets below their book value (0.07x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Aptamer Group PLC's assets grew by 2.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Aptamer Group PLC (2019–2025)
The table below shows the annual total assets of Aptamer Group PLC from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | GBX2.83 Million ≈ $344.82 |
+2.35% |
| 2024-06-30 | GBX2.77 Million ≈ $336.91 |
+0.58% |
| 2023-06-30 | GBX2.75 Million ≈ $334.96 |
-76.10% |
| 2022-06-30 | GBX11.52 Million ≈ $1.40K |
+458.14% |
| 2021-06-30 | GBX2.06 Million ≈ $251.13 |
+48.51% |
| 2020-03-31 | GBX1.39 Million ≈ $169.09 |
-0.53% |
| 2019-03-31 | GBX1.40 Million ≈ $169.99 |
-- |
About Aptamer Group PLC
Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and … Read more